Sho Aki

739 total citations
15 papers, 244 citations indexed

About

Sho Aki is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Sho Aki has authored 15 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Cancer Research. Recurrent topics in Sho Aki's work include Cellular transport and secretion (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Retinal Development and Disorders (3 papers). Sho Aki is often cited by papers focused on Cellular transport and secretion (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Retinal Development and Disorders (3 papers). Sho Aki collaborates with scholars based in Japan and United States. Sho Aki's co-authors include Yoh Takuwa, Kazuaki Yoshioka, Noriko Takuwa, Yasuo Okamoto, Kazuhiro Ishimaru, Tsuyoshi Osawa, Ryuichi Nakahara, Keisuke Maeda, Juanjuan Zhao and Takashi Wada and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Sho Aki

15 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sho Aki Japan 10 136 53 37 35 34 15 244
Jerome Jatzlau Germany 8 128 0.9× 50 0.9× 55 1.5× 21 0.6× 27 0.8× 16 236
Li Gong China 8 161 1.2× 30 0.6× 29 0.8× 25 0.7× 49 1.4× 23 266
Matthew D. Storck United States 10 151 1.1× 47 0.9× 20 0.5× 16 0.5× 24 0.7× 19 246
Justinne R. Guarin United States 6 84 0.6× 62 1.2× 26 0.7× 69 2.0× 41 1.2× 6 261
Pavel Šimara Czechia 12 209 1.5× 25 0.5× 22 0.6× 34 1.0× 20 0.6× 19 318
Yukari Okita Japan 9 155 1.1× 25 0.5× 28 0.8× 20 0.6× 57 1.7× 16 273
Е. Л. Чойнзонов Russia 10 139 1.0× 27 0.5× 25 0.7× 13 0.4× 75 2.2× 71 277
Mardi Fink Canada 4 173 1.3× 63 1.2× 24 0.6× 21 0.6× 36 1.1× 4 368
Ryota Sada Japan 9 243 1.8× 51 1.0× 59 1.6× 17 0.5× 93 2.7× 12 360

Countries citing papers authored by Sho Aki

Since Specialization
Citations

This map shows the geographic impact of Sho Aki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Aki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Aki more than expected).

Fields of papers citing papers by Sho Aki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Aki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Aki. The network helps show where Sho Aki may publish in the future.

Co-authorship network of co-authors of Sho Aki

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Aki. A scholar is included among the top collaborators of Sho Aki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Aki. Sho Aki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Xu, Bo, et al.. (2025). Abstract 1511: Cancer adaptation to acidic tumor microenvironment. Cancer Research. 85(8_Supplement_1). 1511–1511. 1 indexed citations
2.
Aki, Sho, Ryuichi Nakahara, Keisuke Maeda, & Tsuyoshi Osawa. (2023). Cancer metabolism within tumor microenvironments. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(5). 130330–130330. 21 indexed citations
3.
Kato, Miki, Keisuke Maeda, Ryuichi Nakahara, et al.. (2023). Acidic extracellular pH drives accumulation of N1-acetylspermidine and recruitment of protumor neutrophils. PNAS Nexus. 2(10). pgad306–pgad306. 7 indexed citations
4.
Nakahara, Ryuichi, Keisuke Maeda, Sho Aki, & Tsuyoshi Osawa. (2023). Metabolic adaptations of cancer in extreme tumor microenvironments. Cancer Science. 114(4). 1200–1207. 19 indexed citations
5.
Kaneko, Yudai, Kenzo Yamatsugu, Takefumi Yamashita, et al.. (2022). Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment. Cancer Science. 113(12). 4350–4362. 2 indexed citations
6.
Yamatsugu, Kenzo, Hiroto Katoh, Takefumi Yamashita, et al.. (2021). Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system. Protein Expression and Purification. 192. 106043–106043. 4 indexed citations
7.
Shimizu, Shota, Kazuaki Yoshioka, Sho Aki, & Yoh Takuwa. (2021). Class II phosphatidylinositol 3-kinase-C2α is essential for Notch signaling by regulating the endocytosis of γ-secretase in endothelial cells. Scientific Reports. 11(1). 5199–5199. 12 indexed citations
8.
Yoshioka, Kazuaki, Sho Aki, Kazuhiro Ishimaru, et al.. (2020). Class II phosphatidylinositol 3-kinase α and β isoforms are required for vascular smooth muscle Rho activation, contraction and blood pressure regulation in mice. The Journal of Physiological Sciences. 70(1). 18–18. 8 indexed citations
9.
Aki, Sho, Kazuaki Yoshioka, Noriko Takuwa, & Yoh Takuwa. (2020). TGFβ receptor endocytosis and Smad signaling require synaptojanin1, PI3K–C2α-, and INPP4B-mediated phosphoinositide conversions. Molecular Biology of the Cell. 31(5). 360–372. 20 indexed citations
10.
Aki, Sho, Kazuaki Yoshioka, Kouji Kuno, et al.. (2018). Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice. Endocrinology. 160(1). 235–248. 9 indexed citations
11.
Zhao, Juanjuan, Yasuo Okamoto, Kazuhiro Ishimaru, et al.. (2018). Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages. PLoS ONE. 13(5). e0197604–e0197604. 47 indexed citations
12.
Okumura, Kenichiro, Kotaro Yoshida, Kazuaki Yoshioka, et al.. (2018). Photoacoustic imaging of tumour vascular permeability with indocyanine green in a mouse model. European Radiology Experimental. 2(1). 5–5. 23 indexed citations
13.
Yoshioka, Kazuaki, et al.. (2018). The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells. The Journal of Physiological Sciences. 69(2). 263–280. 22 indexed citations
14.
Yoshioka, Kazuaki, Hiromi Mohri, Hiroki Nakata, et al.. (2018). MTMR4, a phosphoinositide‐specific 3’‐phosphatase, regulates TFEB activity and the endocytic and autophagic pathways. Genes to Cells. 23(8). 670–687. 12 indexed citations
15.
Aki, Sho, Kazuaki Yoshioka, Yasuo Okamoto, Noriko Takuwa, & Yoh Takuwa. (2015). Phosphatidylinositol 3-Kinase Class II α-Isoform PI3K-C2α Is Required for Transforming Growth Factor β-induced Smad Signaling in Endothelial Cells. Journal of Biological Chemistry. 290(10). 6086–6105. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026